Guggenheim reaffirms Buy rating and $1,284 price target for Eli Lilly
Guggenheim maintained a Buy rating on Eli Lilly and set a $1,284 price target, implying 11.4% upside versus the Sep 17 close of $1,152.44.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.